SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: Andrew H who wrote (1363)12/5/1997 12:22:00 AM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 4676
 
Andrew:

Antisense (oligophosphotionate) side effect during and one to two hours after infusion (plasma conc.is high); anticoagulation or reversible trombocytopenia, is FDA concern in bleeding Ulcerative colitis. Regardless that 2302 can cure this bleeding.

BI convicted FDA, by protocol revision-IMO, to include this patients.

mz